Drug Discovery Today
Overview
Drug Discovery Today is a renowned scientific journal that focuses on the latest advancements and breakthroughs in the field of drug discovery. It covers a wide range of topics including drug design, target identification, screening technologies, and therapeutic approaches. With its comprehensive and cutting-edge content, this journal serves as a valuable resource for researchers, scientists, and professionals involved in the development of new drugs and therapies.
Details
Details
Abbr.
Drug Discov Today
Start
1996
End
Continuing
Frequency
Twenty-four no. a year, 2001-
p-ISSN
1359-6446
e-ISSN
1878-5832
Country
United Kingdom
Language
English
Specialty
Pharmacology
Metrics
Metrics
h-index / Ranks: 579
215
SJR / Ranks: 1781
1586
CiteScore / Ranks: 651
14.70
JIF / Ranks: 780
7.4
Recent Articles
1.
Regulska K, Gieremek P, Michalak M, Kolenda T, Janiczek-Polewska M, Kozlowska-Maslon J, et al.
Drug Discov Today
. 2025 Mar;
:104331.
PMID: 40089017
Ovarian cancer (OC) has poor survival statistics and increasing prevalence. One of the new options for its therapy could be overcoming platinum resistance. In this review, we have considered the...
2.
Kolekar K, Kumbhar P, Vishwas S, Dua K, Singh S
Drug Discov Today
. 2025 Mar;
:104330.
PMID: 40086788
Over the past decade, dissolving microneedles (DMNs) have emerged as a promising approach for drug delivery to the brain. They are tiny devices designed to penetrate biological barriers, offering a...
3.
Shenton J, Bousnina I, Oropallo M, David R, Weir L, Baker T, et al.
Drug Discov Today
. 2025 Mar;
:104328.
PMID: 40086787
Sharing New Approach Methodology (NAM)-based regulatory experiences is crucial for improving human risk assessment and reducing animal use in drug safety testing. To foster broader adoption, the Biotechnology Innovation Organization...
4.
Schuhmacher A, Hinder M, Brief E, Gassmann O, Hartl D
Drug Discov Today
. 2025 Mar;
:104326.
PMID: 40081820
No abstract available.
5.
Su Q, Cao Y, Zhang H, Li Y, Zhang S
Drug Discov Today
. 2025 Mar;
:104327.
PMID: 40081521
Rheumatoid arthritis (RA) presents a significant challenge in clinical management because of the dearth of effective drugs despite advances in understanding its mechanisms. Drug repurposing has emerged as a promising...
6.
Liu X, Deng C, Deng Y, Luo X, Zhang W
Drug Discov Today
. 2025 Mar;
:104329.
PMID: 40081520
Despite their efficacy, opioids have long been associated with risks of addiction, tolerance, and dependence, leaving an unmet clinical need for pain treatment. Efforts have been devoted to developing novel...
7.
Ibrahim M, Koehler K, Kohler K, Lessl M, Gamalinda M
Drug Discov Today
. 2025 Mar;
30(3):104325.
PMID: 40057114
Many industries face challenges in driving an innovation strategy that sustains value growth and aligns with the company's social responsibility. Bayer is in a unique position as a global diversified...
8.
Lin L, Lucassen M, van der Noort V, Egberts T, Beijnen J, Huitema A
Drug Discov Today
. 2025 Mar;
30(3):104324.
PMID: 40054765
Before real world data (RWD)-derived external control arms (ECAs) can be applied in clinical trials within the field of oncology, it must be determined whether these ECAs can function as...
9.
Kovyrshin A, Tornberg L, Crain J, Mensa S, Tavernelli I, Broo A
Drug Discov Today
. 2025 Mar;
30(3):104323.
PMID: 40054764
Recent innovations in quantum computing hardware and algorithms have raised expectations that practical, real-world applications are within reach. In this context, we explore the potential impact of quantum computing on...
10.
Yao X, Gao C, Sun C, Chen Z, Zhuang J
Drug Discov Today
. 2025 Mar;
30(3):104321.
PMID: 40032137
Non-small-cell lung cancer (NSCLC) is the most common lung cancer subtype, and epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are the core drugs used for its treatment. However, the...